Centro Médico Teknon
| トルコ | オーストリア | スペイン | |
| 陽子線治療 | から $70,000 | から $80,000 | から $25,572 |
| 腹腔鏡下前立腺摘除術 | から $7,500 | から $18,000 | から $14,000 |
| 経尿道的前立腺切除術 | から $3,580 | から $5,500 | から $4,000 |
| 小線源治療 | から $3,465 | から $15,000 | から $10,000 |
| 前立腺癌の密封小線源治療 | から $2,500 | から $9,000 | から $8,000 |
Galceran教授はバル・デブロン病院でスペインの泌尿生殖器がんユニットを率い、900件以上の手術実績と全国臨床試験を有する前立腺がんの専門家です。
Dr. Enrique Grande, MD, PhD, MSc, is a medical oncologist with more than 20 years of experience. He is an international expert in genitourinary and neuroendocrine tumors. He directs the Medical Oncology Department and the One Oncology Madrid Cancer Program at QuirónSalud, Spain’s largest private healthcare network. He leads an integrated, multidisciplinary model with access to targeted therapies and clinical trials.
He is a pioneer in precision oncology. He uses molecular profiling and biomarker-based care. He has authored more than 300 peer-reviewed papers. He serves as a principal investigator and sits on steering committees for many international trials. These studies help set standards of care in urothelial bladder and neuroendocrine tumors. He contributes to guidelines and programs at ESMO, ASCO, ENETS, and EAU.
Spain offers high-precision prostate cancer treatments including robotic surgery, proton therapy, and advanced radiotherapy. Patients access these via JCI-accredited centers in Barcelona and Madrid. Specialized options like the Da Vinci Robotic System and Proteus ONE proton-beam therapy provide minimally invasive alternatives with rapid recovery.
Bookimed Expert Insight: While many search for surgeons, the hidden advantage in Spain is the integration of specialized research centers. For instance, Dr. Raimon Miralbell at Centro Médico Teknon collaborates directly with CERN on radiotherapy protocols. This academic connection often means patients access emerging techniques long before they become global standards.
Patient Consensus: Patients emphasize that while public wait times can reach 6 months, private clinics often schedule surgery within 2 weeks. Many note that requesting a PSMA-PET scan early was crucial for accurate staging and treatment planning.
Early-stage prostate cancer success rates in Spain reach approximately 100% for 5-year relative survival. Localized tumors remain contained within the prostate, making them highly treatable. Spanish specialized centers utilize robotic surgery and targeted radiation to maintain these high therapeutic outcomes while preserving quality of life.
Bookimed Expert Insight: Spain dominates the oncology field by combining high-volume surgical expertise with academic research partnerships. For example, Dr. Raimon Miralbell at Centro Médico Teknon collaborates directly with CERN on advanced treatment protocols. This integration of particle physics and clinical care allows patients to access radiation techniques that are often unavailable in standard hospital settings.
Patient Consensus: Patients note that early detection through regular PSA screening in Spain is vital for achieving the best results. Many emphasize the importance of seeking second opinions on risk groups to choose between active surveillance and robotic surgery.
Prostate cancer treatments in Spain often impact sexual and urinary function, yet advanced techniques help preserve quality of life. Robotic nerve-sparing surgery and proton therapy minimize damage to surrounding tissues. Outcomes depend on the specific procedure, tumor stage, and the expertise of the surgical team.
Bookimed Expert Insight: Spain is a leader in robotic urology, with Hospital Quiron Barcelona performing over 40,000 procedures annually. Our data shows that top surgeons like Dr. Antonio Alcaraz are global pioneers in these techniques. Selecting a high-volume center is vital because surgeons who perform 1,000+ operations typically have better functional preservation rates. While robotic surgery is more expensive, around $31,000, the precision often leads to faster urinary recovery and better potency outcomes.
Patient Consensus: Patients note that urinary control often returns faster than sexual function, which can take over a year. They recommend starting pelvic floor exercises immediately and stocking up on pads for the first six months.
Robotic prostatectomy is widely available in Spain via private medical centers in Barcelona and Madrid. While traditional laparoscopy remains common in public hospitals, private JCI-accredited facilities offer the Da Vinci Robotic System. This approach is now a standard surgical option for localized prostate cancer.
Bookimed Expert Insight: Data shows a high concentration of robotic expertise in Barcelona, where clinics like Hospital Quiron Barcelona and Centro Médico Teknon share elite surgeons. For example, Dr. Antonio Alcaraz leads urology at both institutions. This crossover ensures that patients receive the same surgical quality regardless of which top-tier facility they choose for their procedure.
Patient Consensus: Patients note that while robotic options are limited in the public system, private clinics in major cities offer quick access. They emphasize that the shorter 1-2 week recovery justifies the out-of-pocket costs for the Da Vinci system.
Focal therapy is available in Spain as a precise alternative to full prostate removal. This approach targets only the cancerous lesion using technologies like HIFU or NanoKnife. It is ideal for intermediate-risk patients with localized tumors visible on MRI scans.
Bookimed Expert Insight: Data from leading Spanish centers like Centro Médico Teknon and Hospital Quiron Barcelona shows a shift toward organ-preserving techniques. While robotic prostatectomy remains a staple for advanced cases, the availability of specialized tools like NanoKnife and specialized radiation such as SIRT and IMRT at Teknon allows for highly personalized mapping. If your tumor is visible on a 3-Tesla MRI and confined to one area, these focal options offer a bridge between active surveillance and major surgery.
Patient Consensus: Patients note that focal therapy requires a commitment to long-term monitoring, including regular PSA tests and follow-up imaging. Many emphasize the importance of finding surgeons with high case volumes in specific technologies like HIFU to ensure the best functional outcomes.
Plan to stay in Spain for 14 to 21 days for prostate cancer surgery. This duration allows for the initial procedure, a 2 to 5 day hospital stay, and necessary follow-up care. Most surgeons require patients to remain local until catheter removal, which typically occurs 7 to 14 days post-operatively.
Bookimed Expert Insight: While basic clinical quotes suggest a 7-day stay, our data shows patients often need 14 to 21 days to account for urinary health checks. At clinics like Centro Médico Teknon, diagnostic packages alone specify a 10-day timeline. Including a buffer for post-catheter removal monitoring prevents emergency returns due to potential urinary retention issues.
Patient Consensus: Patients emphasize staying at least 2 weeks because flying with a catheter is very uncomfortable. They also suggest booking flexible flights in case follow-up imaging or PSA tests are delayed by a few days.
Visa requirements for Spain depend on your nationality and treatment length. Citizens of the US, UK, Canada, and EU do not need a visa for stays under 90 days. Others must apply for a Category C Schengen Visa for short-term medical care.
Bookimed Expert Insight: Patient data shows that 90 days is usually sufficient for major procedures. A robotic prostatectomy at Hospital Quiron Barcelona or diagnostics at Centro Medico Teknon typically requires 10–15 days. Even complex Proteus ONE proton therapy at Quironsalud Madrid generally fits within the 45-day window. You likely will not need a long-term Category D visa for these treatments.
Patient Consensus: Patients note that arranging a standard tourist visa is usually sufficient for private hospital care. They emphasize that proving financial capability to the clinic is often more urgent than specialized visa paperwork.